Clinical Trial Update: EBR/GZR for HCV-1b Patients Receiving Hemodialysis [Phase 4]

View source ↗

Summary

Phase 4 trial update of EBR/GZR in Hepatitis C patients on hemodialysis has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• EBR/GZR

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Hepatitis C | Phase 4 | Status: COMPLETED | Results posted: 2020-03-11